Editorial Comment: The effects of pregaba-lin, solifenacin and their combination the-rapy on ureteral double-J stentrelated symp-toms: A randomized controlled clinical trial.
作者信息
Danilovic Alexandre
机构信息
Departamento de Urologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil.
出版信息
Int Braz J Urol. 2022 Mar-Apr;48(2):358-360. doi: 10.1590/S1677-5538.IBJU.2022.02.04.
Abstract
摘要
相似文献
1
Editorial Comment: The effects of pregaba-lin, solifenacin and their combination the-rapy on ureteral double-J stentrelated symp-toms: A randomized controlled clinical trial.
Int Braz J Urol. 2022 Mar-Apr;48(2):358-360. doi: 10.1590/S1677-5538.IBJU.2022.02.04.
2
The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
World J Urol. 2017 Nov;35(11):1669-1680. doi: 10.1007/s00345-017-2051-3. Epub 2017 May 26.
3
A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
World J Urol. 2016 Jul;34(7):963-8. doi: 10.1007/s00345-015-1704-3. Epub 2015 Oct 9.
4
Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
Curr Med Sci. 2019 Oct;39(5):707-718. doi: 10.1007/s11596-019-2096-1. Epub 2019 Oct 14.
5
A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial.
World J Urol. 2015 Nov;33(11):1833-40. doi: 10.1007/s00345-015-1544-1. Epub 2015 Mar 26.
6
The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial.
Int Braz J Urol. 2021 May-Jun;47(3):596-609. doi: 10.1590/S1677-5538.IBJU.2020.0848.
7
Re: Combination of Solifenacin and Tamsulosin May Provide Additional Beneficial Effects for Ureteral Stent-Related Symptoms-Outcomes from a Network Meta-Analysis.
J Urol. 2020 Jun;203(6):1043. doi: 10.1097/JU.0000000000000989. Epub 2020 Mar 11.
8
Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
J Endourol. 2017 Jan;31(1):100-109. doi: 10.1089/end.2016.0663. Epub 2016 Nov 29.
9
Efficacy and safety of solifenacin plus tamsulosin oral controlled absorption system in men with lower urinary tract symptoms: a meta-analysis.
Asian J Androl. 2015 Jan-Feb;17(1):124-34. doi: 10.4103/1008-682X.137685.
10
Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.
Clin Interv Aging. 2016 Sep 19;11:1301-1307. doi: 10.2147/CIA.S115042. eCollection 2016.
本文引用的文献
1
The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial.
Int Braz J Urol. 2021 May-Jun;47(3):596-609. doi: 10.1590/S1677-5538.IBJU.2020.0848.
2
Effects of Silicone Hydrocoated Double Loop Ureteral Stent on Symptoms and Quality of Life in Patients Undergoing Flexible Ureteroscopy for Kidney Stone: A Randomized Multicenter Clinical Study.
J Urol. 2020 Oct;204(4):769-777. doi: 10.1097/JU.0000000000001098. Epub 2020 May 5.
3
Comparison of silicone versus polyurethane ureteral stents: a prospective controlled study.
BMC Urol. 2020 Feb 3;20(1):10. doi: 10.1186/s12894-020-0577-y.
4
Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial.
Arch Esp Urol. 2020 Jan;73(1):54-59.
5
Does a Ureteral Stent with a Smaller Diameter Reduce Stent-Related Bladder Irritation? A Single-Blind, Randomized, Controlled, Multicenter Study.
J Endourol. 2020 Mar;34(3):368-372. doi: 10.1089/end.2019.0482. Epub 2019 Nov 6.
6
Size does matter: ureteral stents with a smaller diameter show advantages regarding urinary symptoms, pain levels and general health.
World J Urol. 2020 Apr;38(4):1059-1063. doi: 10.1007/s00345-019-02829-0. Epub 2019 May 31.
7
Efficacy and Safety of Complete Intraureteral Stent Placement versus Conventional Stent Placement in Relieving Ureteral Stent Related Symptoms: A Randomized, Prospective, Single Blind, Multicenter Clinical Trial.
J Urol. 2019 Jul;202(1):164-170. doi: 10.1097/JU.0000000000000196. Epub 2019 Jun 7.
8
How bothersome double-J ureteral stents are after semirigid and flexible ureteroscopy: a prospective single-institution observational study.
World J Urol. 2019 Jan;37(1):201-207. doi: 10.1007/s00345-018-2376-6. Epub 2018 Jun 19.
9
Does mirabegron relieve ureteric stent-related discomfort? A prospective, randomized, multicentre study.
BJU Int. 2018 Nov;122(5):866-872. doi: 10.1111/bju.14416. Epub 2018 Jul 27.
10
Risks and Benefits of Postoperative Double-J Stent Placement After Ureteroscopy: Results from the Clinical Research Office of Endourological Society Ureteroscopy Global Study.
J Endourol. 2017 May;31(5):446-451. doi: 10.1089/end.2016.0827. Epub 2017 Apr 12.
Zotero 插件